Kodiak Sciences Falls Before Holiday Pause With Eyes on Drug Update
Kodiak Sciences Inc. ended Friday down 3.2% at $36.23, giving up some of the previous day’s jump before the U.S. market’s three-day weekend. The retina-drug maker changed hands between $36.01 and $37.75, with 500,620 shares traded, according to LSEG figures posted on the company’s investor site. Kodiak’s stock is now trading off the outlook for Zenkuda, its experimental eye drug, more than financial numbers. The company’s investor site hadn’t posted any update beyond the May 7 quarterly release as of late Friday.